IMN || Conferences

Proposed PMR guidelines aim to standardize therapy

Posted on: 11/06/2014 - 21:15

PARIS – New international guidelines for polymyalgia rheumatica will focus on standardizing treatment practice across specialties. When adopted, the proposed guidelines will succeed those published...

Field of Interest: Geriatrics
Type: News Item

New definition of clinically meaningful CKD progression

Posted on: 11/06/2014 - 19:25

LAS VEGAS – A landmark study has provided physicians with an improved definition of clinically significant progression of chronic kidney disease for use as a major endpoint in clinical trials as well...

Field of Interest: Dermatology
Type: News Item

New definition of clinically meaningful CKD progression

Posted on: 11/06/2014 - 19:25

LAS VEGAS – A landmark study has provided physicians with an improved definition of clinically significant progression of chronic kidney disease for use as a major endpoint in clinical trials as well...

Field of Interest: Rheumatology
Type: News Item

Mesalazine didn’t help diarrhea-predominant IBS

Posted on: 10/06/2014 - 19:40

CHICAGO – Treating diarrhea-predominant irritable bowel syndrome with mesalazine for 12 weeks failed to improve stool frequency or other symptoms, compared with placebo, in a multicenter, randomized...

Field of Interest: Gastroentero...
Type: News Item

Copaxone lipoatrophy far more common than reported

Posted on: 09/06/2014 - 17:30

DALLAS – The risk of lipoatrophy with glatiramer acetate is greater than 60%, according to a review of 73 multiple sclerosis patients at one clinic. The risk is "substantially higher than...

Field of Interest: Dermatology
Type: News Item

Azathioprine, anti-TNF monotherapy safe in IBD pregnancy

Posted on: 09/06/2014 - 15:35

CHICAGO – Women with inflammatory bowel disease can safely continue monotherapy with azathioprine/6-mercaptopurine or antitumor necrosis–alpha agents during pregnancy to maintain remission, according...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness